Member Info for Maxparker

When company’s stock price falls such a large amount on a single trading day the CEO has to say what has caused this fall or advise share holders they do not know why this has occurred

Still waiting!

Until we get the update on data the SP may continue to slide. Most of us underwater facing a huge delema

We need reassurance, an update to provide some sort of focus where and when Scancell will be in a position to update Pi investors who have stuck by Scancell for a long period of time which I don’t think is an unreasonable request

Ruck, A voice of reason and calm in these uncertain time when geopolitical pressures and inflation dominate the world no wonder there are so many good companies with shares prices in the red. Our fortunes will change and we will look back at this low share price and say l wish I could go been braver and bought more.

Crumbs

Post it on “Linked in” and see if you get a response!

Scancell

If we were working in the lab at Scancell with such amazing progress and completing large volumes of work and fantastic progress being made we may not understand what the problem is not providing the regular updates promised for 2023

However, we are sat on the outside unable to see in. We would like if not RNS info something before the publication of RSN. I know we have started but pi’s don’t know what RM and V know and even they say the SP is derisory ( and it has gone down since then ) so come on Lindy give us something my birthday is in August but would appreciate something before then

Web site disappointing

Out of stock on CBD only massage oils available

Cigarettes with health warning in stock

No CBD gummies on stock

I first bough shares in the days of Zoetic

Big excitement shares went through the roof then crashed

More cautious this time to reinvest

After looking at the out of stock web status on products which should be in stock. Are Chill just going to follow in the same way as zoetic

Just a thought

Hi TF



Cut and paste the link into your browser to view the video . That explains the trial

https://modi-1-study.digitrial.com/

They say timing is everything
Not the RNS l was waiting for
Another commercial failure
Let’s see what the market makes of this?

Interesting to see the price rise 4.41% on the tiny 61k buy volume
The MM’s now want to ramp the price up after dragging it down over 40%
“ buy the expectation sell on news”
Don’t you just love the manipulation.
Let trust we can catch them out on this occasion

Hi Botski
Would be ok to send the audio link for the AGM
Thanks Max

Sun in my eyes should be RW not TW

TW Thank for sharing recent posts.
Very balanced and cautiously optimistic
As I sit on the hotel pool area in Tenerife 29 c
I’m not looking forward to returning today to the UK weather
I’m looking forward to the next couple of weeks with Scancell GLA LTI

Thank you Crumbs
For capturing in a very well crafted mail the essence of what is happening in the current time with the company which is juggling a huge amount of work and buffeting off the external pressures in deciding the right path to follow and achieve the best result.
I agree with all you write and especially “should have sold tons in the high twenties and waited till now to plan the re- invest “
Hindsight is wonderful
Thanks again for being the voice of reason in tough times and hope others long term investors continue to hold for that AACR presentation

Thank Roses for you excellent response
Perhaps this DTH thread can now be put to bed

Matt R raised an interesting point “How is the average investor supposed to evaluate us when they can’t understand scientific speak? As the high level debates continued”
And from wigwammer
“My guess is that cellular immune response has been selected as the primary outcome because it may be more indicative of likely overall survival (the ultimate goal), including circulating tumour and so on, than tumour size”
I agree so. Why would the RNS not clarified the selection / importance of the end point goal
It may be the RNS is the wrong document to clarify this.
There are many many unknowns which need clarification
PR update please Scancell

We need a Business Director to address the smoke and mirrors that are appearing in the press.

Moderna is developing a cancer drug Shares of Moderna rise 2.5% to $164

Scancell has Clinical trials running in hospitals up and down the country
Shares in Scancell drop 12% to £.16p

We could conclude Ichor has now sold the 3 mill shares to MM’s and the share price will slowly recover.

A Business Director may have had the knowledge and time to overt this disaster
Let’s hope our new Chairman has the matter in hand.

Moderna’s announcement to fast track their new skin cancer drug.

We should be also promoting what we are doing

Scancell are conducting clinical trials in hospitals up and down the country proving positive signs that a “Cure for Cancer”may not be to for away.
We hope the impressive early results will grant a fast track status that will allow the trial to continue quickly

Needle free injection
No side effects
Safe
Complete tumour regression
Partial tumour regression
Stabilise cancer progression
No cancer reoccurrence
Prevention of secondary cancer
Proven and enhanced treatment
Low manufacturing cost
Long shelf life
No special storage requirements

Let’s inform the world what we are doing, we need an update delivered in sound bite chunks that everyone can understand and get behind Scancell
To deliver a “Cure for Cancer”

Would be nice to receive positive conformation that it is Ichor and or Calculus selling there shares that is mainly responsible for the fall in SP.

Hi TF
Have send a mail to Kyle @Dow Jones
I will update if or when
Take care Max

I would be pleased to see the valuation of 32p reflected in the SP = 32p instead of an undervalued 18p
Let’s get the positive clinical results out sooon and see that illusive inflection point start to deliver